Sentence examples for donor administration from inspiring English sources

Conclusion: Cervical fluid nitric oxide metabolite level rises after cervical ripening, nitric oxide donor administration, or cervical manipulation, which supports a role for cervical nitric oxide in cervical ripening.

NO donor administration to isolated SSM increased SNO of mtCx43 by 109.2 ± 15.8 %.

Building upon the skills and resources of several campus groups--including donors, administration, and graduate students--has created a successful (and still growing) integrative technology program that allows graduate students to play a key role in their education and future careers.

Conversely, NO donors' administration has shown to stimulate cell proliferation and restore the balance of MMPs [ 31].

By making Iraq a playground for right-wing economic theorists, an employment agency for friends and family, and a source of lucrative contracts for corporate donors, the administration did terrorist recruiters a very big favor.

In fact, blood cells derived from patients following successful alloSCT mirror the long-term effects displayed by blood cells of healthy stem cell donors following administration of granulocyte colony stimulating factor (G-CSF).

By facilitating transfer of gene-targeted cell donors, or administration of cytokine inhibitors, this model provides a novel system in which to test the relative role of innate response cytokines during initiation of but also during chronic phases of inflammatory arthritis.

A6 Rejecting a United Nations official's suggestion that it had been a "stingy" aid donor, the Bush administration announced an increase of $20 million, bringing the total to $35 million, in relief for victims and dispatched an aircraft carrier and other ships to the region for relief operations.

Animal management reflected current human donor management, including administration of vasopressors, inotropes and hormone resuscitation therapy.

Two clinical studies have evaluated the safety of nitrite as a NO donor for human administration by short-term infusion.

Our study has addressed an important question for future development of efficient apoptotic cell-based therapies for promotion of transplantation tolerance: for how long recipient DCs are able to present apoptotic cell-derived allopeptides to donor-reactive T cells following systemic administration of donor apoptotic cells?